Inhibitory effects of in vivo oxidized high-density lipoproteins on platelet aggregation: Evidence from patients with abetalipoproteinemia

FASEB Journal

Volumn 27, Issue 7, 2013, Pages 2855-2861

  Calzada, Catherine ^a   Véricel, Evelyne ^a   Colas, Romain ^a   Guillot, Nicolas ^a   Khoury, Graziella El ^a   Drai, Jocelyne ^a   Sassolas, Agnès ^a   Peretti, Noël ^a,b   Ponsin, Gabriel ^a   Lagarde, Michel ^a   Moulin, Philippe ^a,b  

^a UNIVERSITÉ DE LYON   (France)

^b HOSPICES CIVILS DE LYON   (France)

Author keywords

Hydroxylated fatty acids; Lipid peroxidation; Metabolic disease; Vitamin E

Indexed keywords

ARACHIDONIC ACID; HIGH DENSITY LIPOPROTEIN; MALONALDEHYDE; OXIDIZED HIGH DENSITY LIPOPROTEIN; PROSTAGLANDIN SYNTHASE; TOCOPHEROL; UNCLASSIFIED DRUG;

ABETALIPOPROTEINEMIA; ADULT; ARTICLE; CLINICAL ARTICLE; ENZYME IMMUNOASSAY; FATTY ACID ANALYSIS; FEMALE; HUMAN; IN VIVO STUDY; LIPID COMPOSITION; LIPID PEROXIDATION; MALE; METABOLIC DISORDER; OXIDATION; OXIDATIVE STRESS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; THROMBOCYTE FUNCTION; THROMBOCYTE RICH PLASMA; VEIN PUNCTURE;

HYDROXYLATED FATTY ACIDS; LIPID PEROXIDATION; METABOLIC DISEASE; VITAMIN E;

ABETALIPOPROTEINEMIA; ADENOSINE DIPHOSPHATE; ADULT; ALPHA-TOCOPHEROL; APOLIPOPROTEINS B; ARACHIDONIC ACID; BLOOD PLATELETS; COLLAGEN; FATTY ACIDS, UNSATURATED; FEMALE; HUMANS; LIPOPROTEINS, HDL; MALONDIALDEHYDE; MUTATION; OXIDATION-REDUCTION; OXIDATIVE STRESS; PLATELET AGGREGATION; SCAVENGER RECEPTORS, CLASS B; YOUNG ADULT;

EID: 84879673560     PISSN: None     EISSN: 15306860     Source Type: Journal    
DOI: 10.1096/fj.12-225169     Document Type: Article

References (33)

1. Rye, K. A., Bursill, C. A., Lambert, G., Tabet, F., and Barter, P. J. (2009) The metabolism and anti-atherogenic properties of HDL. J. Lipid Res. 50, S195-S200
2. Kontush, A., and Chapman, M. J. (2006) Functionally defective high-density lipoprotein: a new therapeutic target at the crossroads of dyslipidemia, inflammation, and atherosclerosis. Pharmacol. Rev. 58, 342-374 (Pubitemid 44394906)
3. Zheng, L., Nukuna, B., Brennan, M. L., Sun, M., Goormastic, M., Settle, M., Schmitt, D., Fu, X., Thomson, L., Fox, P. L., Ischiropoulos, H., Smith, J. D., Kinter, M., and Hazen, S. L. (2004) Apolipoprotein A-I is a selective target for myeloperoxidase catalyzed oxidation and functional impairment in subjects with cardiovascular disease. J. Clin. Invest. 114, 529-541 (Pubitemid 39572103)
4. Macdonald, D. L., Terry, T. L., Agellon, L. B., Nation, P. N., and Francis, G. A. (2003) Administration of tyrosyl radical-oxidized HDL inhibits the development of atherosclerosis in apolipoprotein E-deficient mice. Arterioscler. Thromb. Vasc. Biol. 23, 1583-1588 (Pubitemid 37108201)
5. Davi, G., and Patrono, C. (2007) Platelet activation and atherothrombosis. N. Engl. J. Med. 357, 2482-2494
6. Nakano, T., and Nagata, A. (2003) Immunochemical detection of circulating oxidized high-density lipoprotein with antioxidized apolipoprotein A-I monoclonal antibody. J. Lab. Clin. Med. 141, 378-384 (Pubitemid 36737150)
7. Nofer, J. R., Brodde, M. F., and Kehrel, B. E. (2010) High density lipoproteins (HDL), platelets and the pathogenesis of atherosclerosis. Clin. Exp. Pharmacol. Physiol. 37, 726-735
8. Shoulders, C. C., Brett, D. J., Bayliss, J. D., Narcisi, T. M., Jarmuz, A., Grantham, T. T., Leoni, P. R., Bhattacharya, S., Pease, R. J., Cullen, P. M., Levi, S., Byfield, P. G. H., Purkiss, P., and Scott, J. (1993) Abetalipoproteinemia is caused by defects of the gene encoding the 97 kDa subunit of a microsomal triglyceride transfer protein. Hum. Mol. Genet. 2, 2109-2116 (Pubitemid 24003406)
9. Linton, M. F., Farese, R. V., and Young, S. G. (1993) Familial hypobetalipoproteinemia. J. Lipid Res. 34, 521-541 (Pubitemid 23118753)
10. Berriot-Varoqueaux, N., Aggerbeck, L. P., Samson-Bouma, M., and Wetterau, J. R. (2000) The role of the microsomal triglyceride transfer protein in abetalipoproteinemia. Annu. Rev. Nutr. 20, 663-697
11. Di Leo, E., Magnolo, L., Bertolotti, M., Bourbon, M., Carmo Pereira, S., Pirisi, M., Calandra, S., and Tarugi, P. (2008) Variable phenotypic expression of homozygous familial hypobetalipoproteinaemia due to novel APOB gene mutations. Clin. Genet. 74, 267-273
12. Surya, I. I., Mommersteeg, M., Gorter, G., Erkelens, D. W., and Akkerman, J. W. (1991) Abnormal platelet functions in a patient with abetalipoproteinemia. Thromb. Haemost. 65, 306-311
13. Aviram, M., Deckelbaum, R. J., and Brook, J. G. (1985) Platelet function in a case with abetalipoproteinemia. Atherosclerosis 57, 313-323 (Pubitemid 16235919)
14. Shastri, K. M., Carvalho, A. C., and Lees, R. S. (1980) Platelet function and platelet lipid composition in the dyslipoproteinemias. J. Lipid Res. 21, 467-472 (Pubitemid 11235483)
15. Havel, R. J., Eder, H. A., and Bragdon, J. H. (1955) The distribution and chemical composition of ultracentrifugally separated lipoproteins in human serum. J. Clin. Invest. 34, 1345-1353
16. Lagarde, M., Bryon, P. A., Guichardant, M., and Dechavanne, M. (1980) A simple and efficient method for platelet isolation from their plasma. Thromb. Res. 17, 581-588 (Pubitemid 10129052)
17. Bowyer, D. E., Leat, W. M., Howard, A. N., and Gresham, G. A. (1963) The determination of the fatty acid composition of serum lipids separated by thin-layer chromatography and comparison with column chromatography. Biochim. Biophys. Acta 70, 423-431
18. Born, G. V. R. (1962) Aggregation of blood platelets by adenosine diphosphate and its reversal. Nature 194, 927-929
19. Boukhchache, D., and Lagarde, M. (1982) Interactions between prostaglandin precursors during their oxygenation by human platelets. Biochim. Biophys. Acta 713, 386-392 (Pubitemid 13222955)
20. Calzada, C., Coulon, L., Halimi, D., Le Coquil, E., Pruneta-Deloche, V., Moulin, P., Ponsin, G., Véricel, E., and Lagarde, M. (2007) In vitro glycoxidized LDL or LDL isolated from type 2 diabetic patients activate platelets via p38 MAPK. J. Clin. Endocrinol. Metab. 92, 1961-1964
21. Colas, R., Sassolas, A., Guichardant, M., Cugnet-Anceau, C., Moret, M., Moulin, P., Lagarde, M., and Calzada, C. (2011) LDL from obese patients with the metabolic syndrome show increased lipid peroxidation and activate platelets. Diabetologia 54, 2931-2940
22. Imachi, H., Murao, K., Cao, W., Tada, S., Taminato, T., Wong, N. C., Takahara, J., and Ishida, T. (2003) Expression of human scavenger receptor B1 on and in human platelets. Arterioscler. Thromb. Vasc. Biol. 23, 898-904 (Pubitemid 36566184)
23. Patrono, C., and FitzGerald, G. A. (1997) Isoprostanes: potential markers of oxidant stress in atherothrombotic disease. Arterioscler. Thromb. Vasc. Biol. 17, 2309-2315 (Pubitemid 28015962)
24. Clarke, M. W., Hooper, A. J., Headlam, H. A., Wu, J. H. Y., Croft, K. D., and Burnett, J. R. (2006) Assessment of tocopherol metabolism and oxidative stress in familial hypobetalipoproteinemia. Clin. Chem. 52, 1339-1345 (Pubitemid 43956026)
25. Granot, E., and Kohen, R. (2004) Oxidative stress in abetalipoproteinemia patients receiving long-term vitamin E and vitamin A supplementation. Am. J. Clin. Nutr. 79, 226-230 (Pubitemid 41095974)
26. Nofer, J. R., and van Eck, M. (2011) HDL scavenger receptor class B type I and platelet function. Curr. Opin. Lipidol. 22, 277-282
27. Valiyaveettil, M., Kar, N., Ashraf, M. Z., Byzova, T. V., Febbraio, M., and Podrez, E. A. (2008) Oxidized high-density lipoprotein inhibits platelet activation and aggregation via scavenger receptor BI. Blood 111, 1962-1971 (Pubitemid 351451506)
28. Gao, D., Ashraf, M. Z., Kar, N. S., Lin, D., Sayre, L. M., and Podrez, E. A. (2010) Structural basis for the recognition of oxidized phospholipids in oxidized low density lipoproteins by class B scavenger receptors CD36 and SR-BI. J. Biol. Chem. 285, 4447-4454
29. Assinger, A., Schmid, W., Eder, S., Schmid, D., Koller, E., and Volf, I. (2008) Oxidation by hypochlorite converts protective HDL into a potent platelet agonist. FEBS Lett. 582, 778-784
30. Ardlie, N. G., Selley, M. L., and Simons, L. A. (1989) Platelet activation by oxidatively modified low density lipoproteins. Atherosclerosis 76, 117-124 (Pubitemid 19101030)
31. Takahashi, Y., Chiba, H., Matsuno, K., Akita, H., Hui, S. P., Nagasaka, H., Nakamura, H., Kobayashi, K., Tandon, N. N., and Jamieson, G. A. (1996) Native lipoproteins inhibit platelet activation induced by oxidized lipoproteins. Biochem. Biophys. Res. Commun. 222, 453-459 (Pubitemid 26335037)
32. Calkin, A. C., Drew, B. G., Ono, A., Duffy, S. J., Gordon, M. V., Schoenwaelder, S. M., Sviridov, D., Cooper, M. E., Kingwell, B. A., and Jackson, S. P. (2009) Reconstituted high-density lipoprotein attenuates platelet function in individuals with type 2 diabetes mellitus by promoting cholesterol efflux. Circulation 120, 2095-2104
33. Brodde, M. F., Korporaal, S. J., Herminghaus, G., Fobker, M., Van Berkel, T. J., Tietge, U. J., Robenek, H., Van Eck, M., Kehrel, B. E., and Nofer, J. R. (2011) Native high-density lipoproteins inhibit platelet activation via scavenger receptor BI: role of negatively charged phospholipids. Atherosclerosis 215, 374-382 Médicale